GCM
CVS icon

Gladius Capital Management’s CVS Health CVS Stock Holding History

Gladius Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,902
Closed -$1.13M – 113
2024
Q3 		$1.13M Sell
17,902
-1,088
-6% -$63.5K 0.14% 67
2024
Q2 		$1.12M Buy
18,990
+3,372
+22% +$211K 0.14% 70
2024
Q1 		$1.25M Sell
15,618
-307
-2% -$23.5K 0.41% 48
2023
Q4 		$1.26M Sell
15,925
-84
-0.5% -$5.98K 0.2% 73
2023
Q3 		$1.12M Buy
16,009
+2,065
+15% +$146K 0.05% 125
2023
Q2 		$964K Sell
13,944
-1,121
-7% -$79.8K 0.05% 99
2023
Q1 		$1.12M Buy
15,065
+1,798
+14% +$151K 0.07% 110
2022
Q4 		$1.24M Sell
13,267
-444
-3% -$42.8K 0.09% 62
2022
Q3 		$1.31M Sell
13,711
-3,503
-20% -$347K 0.06% 99
2022
Q2 		$1.6M Sell
17,214
-3,679
-18% -$359K 0.08% 78
2022
Q1 		$2.12M Buy
20,893
+2,999
+17% +$315K 0.16% 51
2021
Q4 		$1.85M Buy
+17,894
New +$1.65M 0.15% 64

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Gladius Capital Management's CVS Position: Q4 2024 in Review

Gladius Capital Management sold out of CVS Health (CVS) in Q4 2024, closing a stake of 17,902 shares — an estimated $1.13M sold.

Gladius Capital Management first reported a position in CVS in Q4 2021 and held it in 12 quarters. The position peaked at $2.12M in Q1 2022. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Gladius Capital Management reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 17,902 CVS Health shares in Q4 2024, an estimated $1.13M.
  • Gladius Capital Management first reported a position in CVS Health in Q4 2021 and held it in 12 quarters.
  • Gladius Capital Management's CVS Health position peaked at $2.12M in Q1 2022.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.